QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-cara-therapeutics-stock

Cara Therapeutics shares are trading higher by 15% during Thursday's session. The company earlier announced it engaged Pipe...

 cara-therapeutics-reveals-process-of-exploring-and-reviewing-strategic-alternatives

As of March 31, 2024, the Company had approximately $70 million in cash, cash equivalents, and marketable securities.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION